CureusAug 27, 2025

Stellate ganglion block may help manage long COVID symptoms.

Updated Dec 17, 2025

Abstract

Fifty-two patients with post-acute sequelae of SARS-CoV-2 reported symptom improvements after stellate ganglion block treatment.

Patients received an average of three stellate ganglion block injections.
Most patients experienced improvements in symptoms like brain fog, fatigue, dizziness, and headache.
About a quarter of patients reported at least one short-lived adverse effect.
The duration of symptom improvement varied significantly among patients.
Further randomized clinical trials may be needed to confirm the effectiveness of stellate ganglion blocks for PASC.

Simplified

Introduction The efficacy of stellate ganglion block (SGB) for managing post-acute sequelae of SARS-CoV-2 (PASC) remains an area of active exploration. In this study, we performed a retrospective analysis of PASC symptom improvements following SGB. Methods We performed a retrospective, survey-based cohort study at a single institution of patients with a history of PASC who underwent SGB at one of three different sites within Boston, MA, USA, between September 2022 and September 2024. The intervention was outpatient, office-based, with one or more unilateral SGBs. Results Fifty-two patients were included in the analysis. On average, patients underwent three SGB injections. Most patients reported improvement in PASC symptoms after SGB treatment. The most commonly reported symptoms that showed improvement were brain fog, fatigue, dizziness, and headache. A quarter of patients reported experiencing at least one adverse effect that was mostly short-lived. Conclusion SGB reduced the severity of many PASC symptoms, although there was high variability in the duration of symptom improvement. Further high-quality randomized clinical trials are warranted to investigate SGBs for the effective treatment of PASC.

Full Text

We can’t show the full text here under this license.

View Full Text ↗

Stellate ganglion block may help manage long COVID symptoms.

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the long covid brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the long covid brief